Cogent Biosciences, Inc. (COGT) vs PTC Therapeutics, Inc. (PTCT)
Cogent Biosciences, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. Cogent Biosciences, Inc. and PTC Therapeutics, Inc. are of similar size ($5.5B and $5.2B). Cogent Biosciences, Inc. grew revenue faster over the last twelve months: 110.2% against −42.8%. Cogent Biosciences, Inc. has the higher net margin (0.00% vs −3.80%) and the lower return on invested capital (0.00% vs 15.2%). Across the 17 metrics below, PTC Therapeutics, Inc. leads on 12 and Cogent Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | COGT | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 92.99% | 65.16% |
| Operating margin | 0.00% | 12.45% | 0.00% |
| Net margin | 0.00% | (3.80%) | 0.00% |
| Free cash flow margin | 0.00% | (29.76%) | 0.00% |
| Return on equity | (146.55%) | 20.64% | (57.72%) |
| Return on assets | (68.00%) | (1.30%) | (49.22%) |
| Return on invested capital | 0.00% | 15.16% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack